Pedro P. Granadillo - Jun 13, 2022 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact
Stock symbol
RCKT
Transactions as of
Jun 13, 2022
Transactions value $
$69,924
Form type
4
Date filed
6/15/2022, 09:07 PM
Previous filing
Jun 16, 2021
Next filing
Jun 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +47.7K $0.00 47.7K Jun 13, 2022 Common Stock 47.7K $10.77 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $69.9K +10.3K $6.80 10.3K Jun 13, 2022 Common Stock 10.3K $10.77 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 47,745 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023.
F2 This option represents a right to purchase a total of 10,283 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023. This option was issued to the Reporting Person in lieu of director retainer fees of $70,000.

Remarks:

Exhibit 24: Power of Attorney.